In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum β- lactamase producing strains

International Journal of Antimicrobial Agents

Volumn 15, Issue 4, 2000, Pages 271-275

  Deshpande, Lalitagauri ^a,b   Pfaller, Michael A ^a,b   Jones, Ronald N ^a,b  

^a CAST Laboratories   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CEFQUINOME; CEFTIOFUR; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; VETERINARY MEDICINE;

EID: 0033855812     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00184-9     Document Type: Article

References (12)

1. Salmon S.A., Watts J.L., Case C.A., Hoffman L.J., Wegener H.C., Yancey R.J. Jr Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada and Denmark. J. Clin. Microbiol. 33:1995;2435-2444.
2. Watts J.L., Yancey R.J. Jr, Salmon S.A., Case C.A. A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory diseases in North America. J. Clin. Microbiol. 32:1994;725-731.
3. Erskine R.J., Wilson R.C., Tyler J.W., McClure K.A., Nelson R.S., Spears H.J. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental E. coli-induced mastitis. Am. J. Vet. Res. 56:1995;481-485.
4. Stanek C., Kofler J. Use of sodiun ceftiofur in the combined therapy of complicated septic diseases in cattle Tierarztliche Praxis. Ausgabe G Grosstiere Nutztiere. 26:1998;314-317.
5. Dixon B.A., Issvoran G.S. The activity of ceftiofur sodium for Aeromonas spp. isolated from ornamental fish. J. Wildlife Dis. 28:1992;453-456.
6. Owens W.E., Xiang Z.Y., Ray C.H., Nickerson S.C. Determination of milk and mammary tissue concentration of ceftiofur after intramammary and intrmuscular therapy. J. Dairy Sci. 73:1990;3449-3456.
7. Jones R.N. β-lactamase production by enteric bacilli. Moellering R.C. Therapeutic Decision-Making: Treatment with β-lactamase Inhibitor Combinations. 1999;45-54 PharmaLibri, Montreal.
8. Sanders C.C., Sanders W.E. Jr lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:1992;824-839.
9. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents. Chemother. 39:1995;1211-1233.
10. Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S10. 2000;National Committee for Clinical Laboratory Standards, Wayne, PA.
11. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A. 1999;National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A4. 2000;National Committee for Clinical Laboratory Standards, Wayne, PA.